Bayer Sues FDA Over Approval Of Generic Cattle Antibiotic

Law360, New York (April 11, 2013, 1:37 PM EDT) -- Bayer AG on Wednesday sued the U.S. Food and Drug Administration in Washington federal court over the agency's recent approval of a generic version of cattle medication Baytril 100, saying the cloned product will inevitably be used in an off-label manner that violates a company patent.

The complaint targets a Baytril knockoff marketed by U.K.-based Norbrook Laboratories Ltd., which last month won clearance for bovine respiratory disease antibiotic Enroflox 100, but only for multidose treatment, not the single-dose application covered by Bayer's U.S. Patent Number 5,756,506,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.